REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of May 13, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 13, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 (the “Buyer”).
SECOND AMENDMENT TO SECURITY AGREEMENTSecurity Agreement • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations
This SECOND AMENDMENT TO SECURITY AGREEMENT (the “Amendment”) is dated effective as of the May 13, 2024 (the “Amendment Effective Date”), by and between Novaccess Global Inc., a Colorado corporation (the “Company”) and AJB Capital Investments, LLC, a Delaware limited liability company (“AJB” and together with the Company, the “Parties”).
Stock Purchase AgreementStock Purchase Agreement • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations • Ohio
This Stock Purchase Agreement (this “Agreement”) is entered into effective 17 May 2024 (the “Effective Date”) by NovAccess Global Inc., a Colorado corporation (“Buyer”), and Dawn Digital Limited, a special purpose holding company incorporated in the British Virgin Islands (“Seller”).
PREFUNDED COMMON STOCK PURCHASE WARRANT NOVACCESS GLOBAL INC.Prefunded Common Stock Purchase • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations • Nevada
This PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $117,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), AJB Capital Investments, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NovAccess Global Inc., a Colorado corporation (the “Company”), up to 7,000,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 13, 2024, by and
PREFUNDED COMMON STOCK PURCHASE WARRANT NOVACCESS GLOBAL INC.Prefunded Common Stock Purchase • May 17th, 2024 • NovAccess Global Inc. • Pharmaceutical preparations • Nevada
This PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $117,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), AJB Capital Investments, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NovAccess Global Inc., a Colorado corporation (the “Company”), up to 3,000,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 13, 2024, by and
